Emcure Pharmaceuticals Announces Strong Q1FY25 Results with 17% Revenue Growth and 16% EBITDA Growth
365Telugu.com online news,Pune, August 14th, 2024: Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) today announced its
365Telugu.com online news,Pune, August 14th, 2024: Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) today announced its